Laurence Guédon-Moreau

Summary

Affiliation: CHRU de Lille
Country: France

Publications

  1. ncbi Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study
    Laurence Guédon-Moreau
    Centre Hospitalier Regional Universitaire, F 59037 Lille, France
    Europace 16:1181-8. 2014
  2. pmc Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory
    Laurence Guédon-Moreau
    Hopital Cardiologique, Centre Hospitalier Regional Universitaire, 59 boulevard Leclerq, F 59037 Lille Cedex, France
    Eur Heart J 31:2246-52. 2010
  3. doi Current clinical evidence for remote patient management
    Laurence Guédon-Moreau
    Hopital Cardiologique, CHRU de Lille, Boulevard du Professeur Jules Leclercq, Lille Cedex, France
    Europace 15:i6-i10. 2013
  4. pmc A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial
    Laurence Guédon-Moreau
    Centre Hospitalier Regional et Universitaire, Lille, France
    Eur Heart J 34:605-14. 2013
  5. ncbi Decreased Delivery of Inappropriate Shocks Achieved by Remote Monitoring of ICD: A Substudy of the ECOST Trial
    Laurence Guédon-Moreau
    Centre Hospitalier Regional Universitaire, Hopital Cardiologique, Lille, France
    J Cardiovasc Electrophysiol 25:763-70. 2014
  6. doi Basal exit site of clinical ventricular tachycardia is an independent predictor of antitachycardia pacing failure in implantable cardioverter-defibrillators recipients
    Stéphane Boulé
    Department of Cardiovascular Medicine, Lille University Hospital, Lille, France
    Pacing Clin Electrophysiol 35:1209-16. 2012
  7. doi Clopidogrel increases bleeding complications in patients undergoing heart rhythm device procedures
    Stéphane Boulé
    Department of Cardiovascular Medicine, Lille University Hospital, Lille, France
    Pacing Clin Electrophysiol 35:605-11. 2012
  8. doi Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator
    Fanny Boudghène-Stambouli
    Department of Cardiovascular Medicine, Lille University Hospital, Lille, France
    J Interv Card Electrophysiol 39:177-84. 2014
  9. pmc Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life
    Laurence Guédon-Moreau
    Hopital Cardiologique, Service de cardiologie, CHRU Lille, Lille, France
    Europace 12:634-42. 2010
  10. doi Recurrent unexplained syncope may have a cerebral origin: report of 10 cases of arrhythmogenic epilepsy
    Claude Kouakam
    Department of Cardiology, Arrhythmologic Centre, Lille University Hospital, Lille, France
    Arch Cardiovasc Dis 102:397-407. 2009

Collaborators

Detail Information

Publications11

  1. ncbi Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study
    Laurence Guédon-Moreau
    Centre Hospitalier Regional Universitaire, F 59037 Lille, France
    Europace 16:1181-8. 2014
    ..The Effectiveness and Cost of ICD follow-up Schedule with Telecardiology (ECOST) trial evaluated prospectively the economic impact of long-term remote monitoring (RM) of implantable cardioverter defibrillators (ICDs)...
  2. pmc Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory
    Laurence Guédon-Moreau
    Hopital Cardiologique, Centre Hospitalier Regional Universitaire, 59 boulevard Leclerq, F 59037 Lille Cedex, France
    Eur Heart J 31:2246-52. 2010
    ..We report on a 2-year experience with remote monitoring in 40 recipients of high-voltage ICD leads, prone to fracture and under advisory since October 2007...
  3. doi Current clinical evidence for remote patient management
    Laurence Guédon-Moreau
    Hopital Cardiologique, CHRU de Lille, Boulevard du Professeur Jules Leclercq, Lille Cedex, France
    Europace 15:i6-i10. 2013
    ..Thereby, remote monitoring is clinically much more effective and efficient than conventional follow-up...
  4. pmc A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial
    Laurence Guédon-Moreau
    Centre Hospitalier Regional et Universitaire, Lille, France
    Eur Heart J 34:605-14. 2013
    ..The ECOST trial examined prospectively the long-term safety and effectiveness of home monitoring (HM) of implantable cardioverter defibrillators (ICD)...
  5. ncbi Decreased Delivery of Inappropriate Shocks Achieved by Remote Monitoring of ICD: A Substudy of the ECOST Trial
    Laurence Guédon-Moreau
    Centre Hospitalier Regional Universitaire, Hopital Cardiologique, Lille, France
    J Cardiovasc Electrophysiol 25:763-70. 2014
    ..We examined whether automatic wireless remote monitoring (RM) of ICD, by providing early notifications of triggering events, lowers the incidence of inappropriate shocks...
  6. doi Basal exit site of clinical ventricular tachycardia is an independent predictor of antitachycardia pacing failure in implantable cardioverter-defibrillators recipients
    Stéphane Boulé
    Department of Cardiovascular Medicine, Lille University Hospital, Lille, France
    Pacing Clin Electrophysiol 35:1209-16. 2012
    ..We hypothesized that ATP may be less effective in ICD patients who had basal VT than in those who had apical VT...
  7. doi Clopidogrel increases bleeding complications in patients undergoing heart rhythm device procedures
    Stéphane Boulé
    Department of Cardiovascular Medicine, Lille University Hospital, Lille, France
    Pacing Clin Electrophysiol 35:605-11. 2012
    ..Management of antiplatelet therapy at the time of device implantation remains controversial. This study aimed to assess the risk of bleeding complications in patients receiving clopidogrel at the time of cardiac device surgery...
  8. doi Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator
    Fanny Boudghène-Stambouli
    Department of Cardiovascular Medicine, Lille University Hospital, Lille, France
    J Interv Card Electrophysiol 39:177-84. 2014
    ..This study aims to study the clinical implications of the concomitant use of a left ventricular assist device (LVAD) and an implantable cardioverter-defibrillator (ICD)...
  9. pmc Impact of the control of symptomatic paroxysmal atrial fibrillation on health-related quality of life
    Laurence Guédon-Moreau
    Hopital Cardiologique, Service de cardiologie, CHRU Lille, Lille, France
    Europace 12:634-42. 2010
    ..Patients with atrial fibrillation (AF) consider the related symptoms disruptive to their quality of life (QoL). This study aimed to evaluate the impact of the control of symptomatic paroxysmal AF (PAF) on QoL...
  10. doi Recurrent unexplained syncope may have a cerebral origin: report of 10 cases of arrhythmogenic epilepsy
    Claude Kouakam
    Department of Cardiology, Arrhythmologic Centre, Lille University Hospital, Lille, France
    Arch Cardiovasc Dis 102:397-407. 2009
    ..An underrecognized cause of syncope may occur when partial epileptic discharges profoundly disrupt normal cardiac rhythm, including cardiac asystole, the so-called arrhythmogenic epilepsy (AE)...
  11. doi Temporal analysis of heart rate variability as a predictor of post traumatic stress disorder in road traffic accidents survivors
    Abeer Shaikh Al Arab
    Clinical Investigation Center, CIC 9301 Inserm CHU, Lille, France
    J Psychiatr Res 46:790-6. 2012
    ..The aim of the present study was to determine whether early heart rate variability (HRV) measurement, a biomarker of the ANS function, could act as a predictor of PTSD development after a RTA...